Adjuvant treatment of Graves´ ophthalmopathy with NSAID (aGO study)
1. Background.
When performing MRI / CT / ultrasound of the orbital room 98 % of the patients with Graves´ thyrotoxicosis exhibit changes of ophthalmopathy without clinical symptoms of endocrine ophthalmopathy (Burch 1993). Thus,